2010
DOI: 10.1002/cyto.b.20571
|View full text |Cite
|
Sign up to set email alerts
|

Marginal zone B cell lymphomas with extensive plasmacytic differentiation are neoplasms of precursor plasma cells

Abstract: Occasional marginal zone lymphomas have extensive plasmacytic differentiation (P-MZL). We present an argument based on our data and previous published observations that P-MZL represent neoplasms of precursor plasma cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 41 publications
0
14
0
Order By: Relevance
“…The current WHO-classification of Tumors of Hematopoietic and Lymphoid Tissue 2017 [6] classifies localized plasmacytic-differentiated B cell lymphoproliferations (e.g., in the skin, in the stomach, and in the salivary glands) as plasmacytic-differentiated marginal zone lymphomas, presupposing that a small B cell component is detectable within the biopsy specimen. Some authors claim that plasmacyticdifferentiated marginal zone lymphomas have to be classified as pure plasma cell neoplasms, because they exhibit the immunophenotype of plasma cells rather than the immunophenotype of mature B cells in flow cytometry analysis [20]. The question whether a relatively small B cell component in localized amyloidosis is part of the neoplastic clone or not is currently unknown, and the classification of a lymphoproliferation associated with localized AL amyloidosis is an unsolved issue.…”
Section: Discussionmentioning
confidence: 99%
“…The current WHO-classification of Tumors of Hematopoietic and Lymphoid Tissue 2017 [6] classifies localized plasmacytic-differentiated B cell lymphoproliferations (e.g., in the skin, in the stomach, and in the salivary glands) as plasmacytic-differentiated marginal zone lymphomas, presupposing that a small B cell component is detectable within the biopsy specimen. Some authors claim that plasmacyticdifferentiated marginal zone lymphomas have to be classified as pure plasma cell neoplasms, because they exhibit the immunophenotype of plasma cells rather than the immunophenotype of mature B cells in flow cytometry analysis [20]. The question whether a relatively small B cell component in localized amyloidosis is part of the neoplastic clone or not is currently unknown, and the classification of a lymphoproliferation associated with localized AL amyloidosis is an unsolved issue.…”
Section: Discussionmentioning
confidence: 99%
“…The phenomenon of the lack of CD138 expression in malignant plasma cells of MZL with plasmacytic differentiation has been described previously [ 13 , 14 ]. In our case, morphologically mature malignant plasma cells (Marschalko type) in the intervening cords also exhibited an aberrant plasma cell-related antigen profile.…”
Section: Discussionmentioning
confidence: 85%
“…Several authors have noted that the distinction between plasmacytoma and MALT lymphoma with plasma cell differentiation is sometimes ambiguous [ 8 , 15 ]. Meanwhile, Meyerson et al investigated both diseases and related disorders by using flow cytometric analysis and described that plasma cells observed in marginal zone lymphoma resembled normal precursor plasma cells, whereas those observed in plasma cell myeloma were similar to more mature marrow plasma cells [ 16 ]. Regardless of the pathogeneses of the two diseases, the similarities in the endoscopic images observed in the present case and the case of plasmacytoma reported by Harada et al [ 6 ] may reflect common pathological features shared between the two cases, for example, proliferation of plasma cells.…”
Section: Discussionmentioning
confidence: 99%